Lifespan persistence of ADHD: The life transition model and its application

Journal of Clinical Psychiatry

Volumn 73, Issue 2, 2012, Pages 192-201

  Turgay, Atilla ^a   Goodman, David W ^b   Asherson, Philip ^c   Lasser, Robert A ^d   Babcock, Thomas F ^d   Pucci, Michael L ^e   Barkley, Russell ^f,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SHIRE   (United States)

^e SCI Scientific Communications and Information   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; BEHAVIORAL STRESS; CLINICAL FEATURE; COGNITION; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; LIFESPAN; MEDICAL SPECIALIST; MENTAL HEALTH; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RECOGNITION; REMISSION; REVIEW;

EID: 84857718458     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06628     Document Type: Review

References (129)

1. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7):894-921. doi:10.1097/chi.0b013e318054e724 PubMed
2. Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed. 2010;95(1):24-27. doi:10.136/adc.209. 175943 PubMed
3. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10(1):67. doi:10.186/1471-24X-10-67 PubMed
4. Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204-211. doi:10.192/bjp.bp.107.04827 PubMed
5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723. doi:10.176/api.ajp.163.4.716 PubMed (Pubitemid 44464584)
6. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402-409. doi:10.192/bjp.bp.106.034389 PubMed (Pubitemid 46706952)
7. Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry. 2004; 13(suppl 1):17-30. PubMed doi:10.107/s0787-04-102-x
8. American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000: 85-93.
9. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948. doi:10.176/api.ajp.164.6.942 PubMed (Pubitemid 46972911)
10. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet. 2009;126(1):13-50. doi:10.107/s0439-09-063-4 PubMed
11. Tahir E, Yazgan Y, Cirakoglu B, et al. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry. 2000;5(4):396-404. doi:10.1038/sj.mp.4074 PubMed (Pubitemid 30455953)
12. Kustanovich V, Ishii J, Crawford L, et al. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry. 2004;9(7):711-717. doi:10.1038/sj.mp.40146 PubMed (Pubitemid 38932176)
13. Bobb AJ, Addington AM, Sidransky E, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):67-72. doi:10.102/ajmg.b.30142 PubMed (Pubitemid 40411112)
14. Durston S, Fossella JA, Mulder MJ, et al. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry. 2008;47(1):61-67. doi:10.1097/chi.0b013e31815a5f17 PubMed
15. Roman T, Schmitz M, Polanczyk GV, et al. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet. 2002;114(2):154-158. doi:10.102/ajmg.10194 PubMed (Pubitemid 34160466)
16. Roman T, Schmitz M, Polanczyk GV, et al. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am J Med Genet B Neuropsychiatr Genet. 2003;120B(1):116-120. doi:10.102/ajmg.b.2018 PubMed (Pubitemid 37059387)
17. Valera EM, Faraone SV, Murray KE, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361-1369. doi:10.1016/j.biopsych.206.06.01 PubMed (Pubitemid 46855763)
18. Plessen KJ, Bansal R, Zhu H, et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2006;63(7):795-807. doi:10.101/archpsyc.63.7.795 PubMed
19. Soliva JC, Carmona S, Fauquet J, et al. Neurobiological substrates of social cognition impairment in attention-deficit hyperactivity disorder: gathering insights from seven structural and functional magnetic resonance imaging studies. Ann N Y Acad Sci. 2009;1167(1):212-220. doi:10.1/j.1749-632. 209.04604.x PubMed
20. Ginsberg LD, Jain R, Murphy WR, et al. Response and symptomatic remission with open-label coadministration of guanfacine extended release and stimulants for ADHD. Poster presented at: the 163rd Annual Meeting of the American Psychiatric Association; May 22-26, 2010; New Orleans, LA.
21. Makris N, Biederman J, Valera EM, et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/ hyperactivity disorder. Cereb Cortex. 2007;17(6):1364-1375. doi:10.1093/cercor/ bhl047 PubMed (Pubitemid 47343622)
22. Seidman LJ, Valera EM, Makris N, et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry. 2006;60(10):1071-1080. doi:10.1016/j.biopsych.206.04. 031 PubMed (Pubitemid 44754859)
23. Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry. 2005;57(11):1273-1284. doi:10.1016/j.biopsych.205. 01.034 PubMed (Pubitemid 40798546)
24. Rubia K, Overmeyer S, Taylor E, et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry. 1999;156(6):891-896. PubMed (Pubitemid 29260344)
25. Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry. 1999;45(12):1542-1552. doi:10.1016/S06-323(9) 083-9 PubMed (Pubitemid 29292830)
26. Skirrow C, McLoughlin G, Kuntsi J, et al. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Rev Neurother. 2009;9(4):489-503. doi:10.1586/ern.09.2 PubMed
27. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997; 121(1):65-94. doi:10.1037/03-2909.121.1.65 PubMed (Pubitemid 127705285)
28. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry. 1996;37(1):51-87. doi:10.1/j.1469-7610.196.tb01380.x PubMed (Pubitemid 26090587)
29. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818. PubMed (Pubitemid 30249663)
30. Weiss G, Trokenberg-Hechtman L. Hyperactive Children Grown Up, ADHD in Children, Adolescents, and Adults. 2nd ed. New York, NY: The Guilford Press; 1996.
31. McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2004;161(11):1948-1956. doi:10.176/api.ajp.161.1.1948 PubMed (Pubitemid 39441393)
32. Gibbins C, Weiss M. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep. 2007;9(5):420-426. doi:10.107/s1920-07-05-1 PubMed (Pubitemid 47565024)
33. Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004;65(suppl 3):27-37. PubMed
34. Lee SI, Schachar RJ, Chen SX, et al. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. J Child Psychol Psychiatry. 2008;49(1):70-78. doi:10.1/j.1469-7610.207.01784.x PubMed
35. Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002; 111(2):279-289. doi:10.1037/021-843X.1.2.279 PubMed (Pubitemid 34441206)
36. American Psychiatric Association. Attention Deficit/Hyperactivity Disorder. 314.0x. Summary of changes under consideration for ADHD. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=383. Accessed November 11, 2011.
37. New York State Department of Health. Resource Directory for Children and Young Adults with Special Health Care Needs. http://www.health.state.ny.us/ publications/0548.pdf. Accessed November 11, 2011.
38. American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110(6, pt 2): 1304-1306. PubMed
39. Dixon LB, Dickerson F, Bellack AS, et al Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36(1):48-70. doi:10.1093/schbul/sbp15 PubMed
40. Brown AH, Cohen AN, Chinman MJ, et al. EQUIP: implementing chronic care principles and applying formative evaluation methods to improve care for schizophrenia: QUERI Series. Implement Sci. 2008;3(1):9. doi:10.186/1748-5908-3- 9 PubMed
41. Tuchman LK, Slap GB, Britto MT. Transition to adult care: experiences and expectations of adolescents with a chronic illness. Child Care Health Dev. 2008;34(5):557-563. doi:10.1/j.1365-214.208.084.x PubMed
42. Kulig J. Advances in medical management of asthma, headaches, and fatigue. Med Clin North Am. 2000;84(4):829-850, vi. doi:10.1016/S025-7125(05) 70263-7 PubMed
43. Brumfield K, Lansbury G. Experiences of adolescents with cystic fibrosis during their transition from paediatric to adult health care: a qualitative study of young Australian adults. Disabil Rehabil. 2004;26(4):223-234. doi:10.1080/09638280310164924 PubMed (Pubitemid 38325153)
44. Escher JC. Transition from pediatric to adult health care in inflammatory bowel disease. Dig Dis. 2009;27(3):382-386. doi:10.159/028578 PubMed
45. Nasr SZ. Cystic fibrosis in adolescents and young adults. Adolesc Med. 2000;11(3):589-603. PubMed
46. Spencer CH, Fife RZ, Rabinovich CE. The school experience of children with arthritis: coping in the 1990s and transition into adulthood. Pediatr Clin North Am. 1995;42(5):1285-1298. PubMed
47. Hagood JS, Lenker CV, Thrasher S. A course on the transition to adult care of patients with childhood-onset chronic illnesses. Acad Med. 2005; 80(4):352-355. doi:10.1097/018-205040-09 PubMed (Pubitemid 40446173)
48. Scal P. Transition for youth with chronic conditions: primary care physicians' approaches. Pediatrics. 2002;110(6, pt 2):1315-1321. PubMed (Pubitemid 35425173)
49. McPherson M, Weissman G, Strickland BB, et al. Implementing community-based systems of services for children and youths with special health care needs: how well are we doing? Pediatrics. 2004;113(5 suppl): 1538-1544. PubMed (Pubitemid 38580675)
50. Reiss J, Gibson R. Health care transition: destinations unknown. Pediatrics. 2002;110(6, pt 2):1307-1314. PubMed (Pubitemid 35425172)
51. Lotstein DS, Ghandour R, Cash A, et al. Planning for health care transitions: results from the 2005-2006 National Survey of Children With Special Health Care Needs. Pediatrics. 2009;123(1):e145-e152. doi:10.1542/peds.208-1298 PubMed
52. Schmidt S, Petermann F. Developmental psychopathology: attention deficit hyperactivity disorder (ADHD). BMC Psychiatry. 2009;9(1):58. doi:10.186/1471-24X-9-58 PubMed
53. Young S, Amarasinghe JM. Practitioner review: non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry. 2010;51(2):116-133. doi:10.1/j.1469-7610.209.02191.x PubMed
54. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002;31(2):285-293. doi:10.1093/ije/31.2.285 PubMed (Pubitemid 34537777)
55. Bodenheimer T, Lorig K, Holman H, et al. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469-2475. doi:10.101/jama.28.19.2469 PubMed (Pubitemid 35340544)
56. Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234-247. PubMed (Pubitemid 23155671)
57. Folkman S, Moskowitz JT. Coping: pitfalls and promise. Annu Rev Psychol. 2004;55(1):745-774. doi:10.146/anurev.psych.5.090902.141456 PubMed
58. Hoza B. Peer functioning in children with ADHD. Ambul Pediatr. 2007; 7(1 suppl):101-106. doi:10.1016/j.ambp.206.04.01 PubMed (Pubitemid 46140753)
59. Reiff MI, Stein MT. Attention-deficit/hyperactivity disorder evaluation and diagnosis: a practical approach in office practice. Pediatr Clin North Am. 2003;50(5):1019-1048. doi:10.1016/S031-395(03)07-4 PubMed (Pubitemid 37204483)
60. Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192-202. doi:10.1097/01.chi.0189134.97436. e2 PubMed (Pubitemid 43151524)
61. Barkley RA, Guevremont DC, Anastopoulos AD, et al. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics. 1993;92(2):212-218. PubMed (Pubitemid 23226834)
62. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-128. doi:10.1016/j.jsr.206.09.04 PubMed (Pubitemid 46321543)
63. Biederman J, Petty CR, Fried R, et al. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2008;69(8):1217-1222. doi:10.408/JCP. v69n0803 PubMed
64. Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1,001 adults in the community. J Clin Psychiatry. 2006;67(4):524-540. doi:10.408/JCP.v67n0403 PubMed (Pubitemid 43764229)
65. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/ hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(suppl 1):i26-i31. doi:10.107/s0406-06-104-4 PubMed
66. Biederman J, Monuteaux MC, Spencer T, et al. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124(1):71-78. doi:10.1542/peds.208-347 PubMed
67. Daviss WB, Birmaher B, Diler RS, et al. Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? J Child Adolesc Psychopharmacol. 2008;18(3):257-264. doi:10.1089/cap.207.010 PubMed
68. Halmøy A, Fasmer OB, Gillberg C, et al. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13(2):175-187. doi:10.17/10870547083297 PubMed
69. Glasgow RE, McKay HG, Piette JD, et al. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44(2):119-127. doi:10.1016/S0738- 391(0)0186-5 PubMed (Pubitemid 32677955)
70. Erikson EH. Identity and the Life Cycle. New York, NY: W W Norton & Company, Inc; 1980.
71. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115(6):1734-1746. doi:10.1542/peds.204-1959 PubMed (Pubitemid 43843185)
72. McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194(3):273-277. doi:10.192/bjp.bp.107.045245 PubMed
73. Biederman J, Faraone S, Milberger S, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35(3):343-351. doi:10.1097/04583-196030-016 PubMed (Pubitemid 26072292)
74. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2006.
75. Anckarsäter H, Stahlberg O, Larson T, et al. The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am J Psychiatry. 2006;163(7):1239-1244. PubMed (Pubitemid 44464453)
76. Rettew DC, McKee L. Temperament and its role in developmental psychopathology. Harv Rev Psychiatry. 2005;13(1):14-27. doi:10.1080/ 1067320590923146 PubMed (Pubitemid 40446362)
77. Nigg JT, Goldsmith HH, Sachek J. Temperament and attention deficit hyperactivity disorder: the development of a multiple pathway model. J Clin Child Adolesc Psychol. 2004;33(1):42-53. doi:10.1207/S1537424JCP301-5 PubMed (Pubitemid 38341547)
78. Williams ED, Reimherr FW, Marchant BK, et al. Personality disorder in ADHD, part 1: assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate. Ann Clin Psychiatry. 2010;22(2):84-93. PubMed
79. DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
80. Conners CK. Conners' Rating Scales-Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems Inc; 1997.
81. Wolraich ML, Hannah JN, Baumgaertel A, et al. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr. 1998;19(3):162-168. doi:10.1097/04703-198060-03 PubMed (Pubitemid 128456243)
82. Wolraich ML, Lambert W, Doffing MA, et al. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003;28(8):559-567. doi: 10.1097/DBP.0b013e3181d5a328 PubMed (Pubitemid 37449138)
83. Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54. doi:10.186/147-7525-1-54 PubMed
84. Patrick DL, Edwards TC, Topolski TD. Adolescent quality of life, part 2: initial validation of a new instrument. J Adolesc. 2002;25(3):287-300. doi:10.106/jado.202.0471 PubMed (Pubitemid 41115228)
85. Roth RM, Isquith PK, Gioia GA. Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A). Lutz, FL: Psychological Assessment Resources, Inc; 1999.
86. Weiss M. Weiss Functional Impairment Rating Scale Self-Report (WFIRS-S). Vancouver, British Columbia: University of British Columbia; 2000.
87. DuPaul GJ, Rapport MD, Perriello LM. Teacher ratings of academic skills: the development of the Academic Performance Rating Scale. School Psych Rev. 1991;20(2):284-300.
88. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). Technical Manual. New York, NY: Multi-Health Systems; 1999.
89. Adler L, Kessler RC, Spencer T. with the World Health Organization. Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist Instructions. http://webdoc.nyumc.org/nyumc/files/psych/attachments/psych-adhd-checklist.pdf. Accessed November 11, 2011.
90. Brod M, Johnston J, Able S, et al. Validation of the Adult Attention-Deficit/Hyperactivity Disorder Quality-of-Life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006;15(1): 117-129. doi:10.107/s136-05-8325-z PubMed (Pubitemid 43097592)
91. Stanford Test of Academic Skills. 4th ed. Boston, MA: Psychological Corporation; 1996.
92. Landgraf JM. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord. 2007;11(3):351-362. doi:10.17/10870547072940 PubMed
93. Brown TE. Brown Attention-Deficit Hyperactivity Disorder Scales for Adolescents and Adults. San Antonio, TX: The Psychological Corporation; 1996.
94. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull. 1997;33(1): 13-16. PubMed (Pubitemid 27184189)
95. Shaw P, Lerch J, Greenstein D, et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2006; 63(5):540-549. doi:10.101/archpsyc.63.5.540 PubMed
96. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21-31. doi:10.1097/chi.0b013e31815a56f1 PubMed
97. Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008; 165(5):597-603. PubMed (Pubitemid 351705336)
98. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1):179-185. doi:10.1542/peds.1.1.179 PubMed (Pubitemid 36071051)
99. Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916-921. doi:10.101/archpedi.162.10.916 PubMed
100. Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgrad Med. 2008;120(3):48-59. doi:10.3810/pgm.208.09.1907 PubMed
101. Wilens TE, Dodson W. A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry. 2004;65(10): 1301-1313. doi:10.408/JCP.v65n103 PubMed
102. Gotlieb EM, Gotlieb JS. Helping adolescents with attention-deficit/ hyperactivity disorder transition toward adulthood. Adolesc Med State Art Rev. 2009;20(1):203-222, xi. PubMed
103. Wong IC, Asherson P, Bilbow A, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009;13(50):iii-iv, ix-xi, 1-120. PubMed
104. Young S, Gray K, Bramham J. A phenomenological analysis of the experience of receiving a diagnosis and treatment of ADHD in adulthood: a partner's perspective. J Atten Disord. 2009;12(4):299-307. doi:10.17/108705470731659 PubMed
105. Levander A, Raccuia I. Entrepreneurial Profiling (Stimuli, Reaction, Action). A Cognitive Approach to Entrepreneurship. Stockholm, Sweden: Stockholm School of Entrepreneurship; 2001.
106. Kooij JJS, Buitelaar JK, van den Oord EJ, et al. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817-827. doi:10.1017/S03291704037X PubMed (Pubitemid 40873382)
107. Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23(1):93-102. doi:10.2165/019053-20523010-08 PubMed (Pubitemid 40194012)
108. Lara C, Fayyad J, de Graaf R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009;65(1):46-54. doi:10.1016/j.biopsych.208.10.05 PubMed
109. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people, and adults. NICE Clinical Guideline 72. http://www.nice.org.uk/ nicemedia/pdf/ADHDFullGuideline.pdf. Accessed November 11, 2011.
110. Meaux JB, Hester C, Smith B, et al. Stimulant medications: a trade-off? the lived experience of adolescents with ADHD. J Spec Pediatr Nurs. 2006;11(4):214-226. doi:10.1/j.174-615.206.063.x PubMed
111. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989; 261(22):3273-3277. PubMed (Pubitemid 19143549)
112. Williamson P, Koro-Ljungberg ME, Bussing R. Analysis of critical incidents and shifting perspectives: transitions in illness careers among adolescents with ADHD. Qual Health Res. 2009;19(3):352-365. doi:10.17/ 1049732308329683 PubMed
113. Adler L, Shaw D, Sitt D, et al. Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Prim Psychiatry. 2009; 16(5):57-63. http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2089. Accessed November 11, 2011.
114. Fremont WP, Nastasi R, Newman N, et al. Comfort level of pediatricians and family medicine physicians diagnosing and treating child and adolescent psychiatric disorders. Int J Psychiatry Med. 2008;38(2): 153-168. doi:10.2190/PM.38.2.c PubMed
115. Callahan ST, Cooper WO. Uninsurance and health care access among young adults in the United States. Pediatrics. 2005;116(1):88-95. doi:10.1542/peds. 204-149 PubMed
116. Young S, Gudjonsson GH, Wells J, et al. Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population. Pers Individ Dif. 2009;46(3):265-269. doi:10.1016/j.paid.208.10.03
117. Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines. CAP-Guidelines 3rd edition. http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011. pdf. Accessed November 11, 2011.
118. Pelham WE Jr, Fabiano GA. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2008;37(1):184-214. doi:10.1080/1537410701818681 PubMed
119. Evans SW, Serpell ZN, Schultz BK, et al. Cumulative benefits of secondary school-based treatment of students with attention deficit hyperactivity disorder. School Psych Rev. 2007;36(2):256-273.
120. Virta M, Vedenpää A, Grönroos N, et al. Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord. 2008;12(3):218-226. doi:10.17/108705470731657 PubMed
121. Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831-842. doi:10.1016/j.brat.204.07.01 PubMed (Pubitemid 40719607)
122. Bramham J, Young S, Bickerdike A, et al. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5): 434-441. doi:10.17/1087054708314596 PubMed
123. Solanto MV, Marks DJ, Mitchell KJ, et al. Development of a new psychosocial treatment for adult ADHD. J Atten Disord. 2008;11(6): 728-736. doi:10.17/108705470730510 PubMed
124. Pfiffner LJ, Yee Mikami A, Huang-Pollock C, et al. A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1041-1050. doi:10.1097/chi.0b013e318064675f PubMed (Pubitemid 47220686)
125. Tamm L, Hughes C, Ames L, et al. Attention training for school-aged children with ADHD: results of an open trial. J Atten Disord. 2010; 14(1):86-94. doi:10.17/108705470934746 PubMed
126. So CY, Leung PW, Hung SF. Treatment effectiveness of combined medication/behavioural treatment with Chinese ADHD children in routine practice. Behav Res Ther. 2008;46(9):983-992. doi:10.1016/j.brat.208.06.07 PubMed
127. van den Hoofdakker BJ, Nauta MH, van der Veen-Mulders L, et al. Behavioral parent training as an adjunct to routine care in children with attention-deficit/hyperactivity disorder: moderators of treatment response. J Pediatr Psychol. 2010;35(3):317-326. doi:10.1093/jpepsy/jsp060 PubMed
128. Schultz BK, Evans SW. Preventing failure among middle school students with attention deficit hyperactivity disorder: a survival analysis. School Psych Rev. 2009;38(1):14-27. http://www.nasponline.org/publications/spr/pdf/ spr381schultz.pdf. Accessed November 11, 2011.
129. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875-880.